Literature DB >> 29766809

Associations between Depressive Disorders and Inflammatory Rheumatic Diseases.

Özkan Varan1, Hakan Babaoğlu1, Berna Göker1.   

Abstract

Depressive disorders, are not only common but also among the leading causes of disability worldwide. They are associated with increased incidences of various other diseases. It has been shown that in patients with autoimmune diseases, when depression coexists, the quality of life is worse and medical treatment and management is compromised. Depression-like symptoms, such as fatigue and disinterest are also common in inflammatory rheumatic diseases and often associated with poor quality of life. Medical therapy targeting inflammation results in alleviation of these symptoms in many patients. Interestingly, there is cumulating evidence suggesting potential roles of inflammatory cytokines in the pathogenesis of major depression. Effects of some of the biological agents used in rheumatic diseases have been studied on depressive disorders. Results have been controversial and further studies are needed in this area. These findings suggest associations between depression and inflammatory rheumatic diseases and raise the possibility that treatment of one of them might influence the outcome of the other. We have reviewed the current literature on associations between depression and inflammatory rheumatologic diseases, such as rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome and ankylosing spondylitis. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Ankylosing spondylitis; Depression; Inflammation; Rheumatic; Rheumatoid arthritis; Sjögren's syndrome; Systemic lupus erythematosus.

Mesh:

Substances:

Year:  2018        PMID: 29766809     DOI: 10.2174/1568026618666180516100805

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  5 in total

1.  Risk of Ankylosing Spondylitis in Patients With Endometriosis: A Population-Based Retrospective Cohort Study.

Authors:  Zhihua Yin; Hui-Ying Low; Brian Shiian Chen; Kuo-Shu Huang; Yue Zhang; Yu-Hsun Wang; Zhizhong Ye; James Cheng-Chung Wei
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

2.  Fatigue in inflammatory rheumatic disorders: pathophysiological mechanisms.

Authors:  S Mechiel Korte; Rainer H Straub
Journal:  Rheumatology (Oxford)       Date:  2019-11-01       Impact factor: 7.580

3.  Inflammation and Coronary Heart Disease Risk in Patients with Depression in China Mainland: A Cross-Sectional Study.

Authors:  Lina Zhou; Xiancang Ma; Wei Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-09       Impact factor: 2.570

4.  SAPHO syndrome: the supposed trigger by isotretinoin, the efficacy of adalimumab and the specter of depressive disorder: a case report.

Authors:  Michele Luzzati; Gabriele Simonini; Cesare Filippeschi; Teresa Giani; Sandra Trapani
Journal:  Ital J Pediatr       Date:  2020-11-13       Impact factor: 2.638

5.  Quality of life, anxiety and depressive disorders in patients with extrasystolic arrhythmia.

Authors:  Alexey Y Mikhaylov; Alexei V Yumashev; Eugeny Kolpak
Journal:  Arch Med Sci       Date:  2020-11-29       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.